Seeking Alpha

INHX
Inhibitex, Inc.

5/26/2012, 11:31 AM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
INHX Market Currents more »
  • January 27 Idenix Pharmaceuticals (IDIX) -9.6% after Stifel Nicolaus downgrades shares to Sell from Hold at Stifel Nicolaus, which believes the "significant difference" in potency existing between IDIX's hepatitis C drug and those made by Pharmasset (VRUS) and Inhibitex (INHX) has important implications on how remaining "potential consolidators" strategically view the companies.
    Comment!
    [Healthcare, On the Move]
INHX in Focus more »
INHX Press Releases and Filings more »
Currently, there are no press releases or filings on INHX.
INHX Latest Transcript more »
Currently, there are no transcripts for INHX.
INHX Cramer more »
Currently, there are no Cramer articles on INHX.
INHX Instablog posts more »
  • The Hepatitis C Gold Rush - Looking For The Right Fit For Idenix's Drug IDX184
    Tue, Feb 14 • EXPstocktrader • 1 Comment
  • Bull Market Coming? Maybe. Now Let's Wait For Consolidation/pullback
    Sun, Jan 29 • mirkotoscano • Comment!
  • Bristol-Myers Signs Agreement to Acquire Inhibitex for 160% Premium
    Mon, Jan 9 • Disclosure Insight • Comment!
  • ValuEngine Rates Medical Stocks
    Fri, Dec 16, 2011 • Steve Hach • Comment!
  • Data on Medical Stocks, Market Levels, and ADM from ValuEngine.com
    Fri, May 20, 2011 • Steve Hach • Comment!
Write a post on INHX
INHX StockTalks
INHX vs. ETF Alternatives
Company Description
Currently, there's no company description for INHX.
Sector: Healthcare
Industry: Biotechnology
Country: United States